Johnson: Vaccine Approval Is a ‘Triumph for British Science’

A triumph for British science was described by the Prime Minister of the United Kingdom, Boris Johnson, the approval received by the vaccine of the University of Oxford and AstraZeneca against the coronavirus for use in Britain.

“It’s really fantastic news – and a triumph for British science,” Johnson said on Twitter.

It is truly fantastic news – and a triumph for British science – that the @UniofOxford /@AstraZeneca vaccine has been approved for use.

We will now move to vaccinate as many people as quickly as possible. pic.twitter.com/cR4pRdZJlT

— Boris Johnson (@BorisJohnson) December 30, 2020

“We will now move to vaccinate as many people as quickly as possible,” he added.

For his part, Health Minister Matt Hancock stressed that the approval of the vaccine offers a way out of the pandemic until the spring, when millions of vulnerable people have already been vaccinated.

He added that the recommended 12-week interval between the first and second doses of the AstraZeneca vaccine is “very helpful”, as this way more people will be able to take the first dose, which alone offers a large percentage. protection.

Urgent approval of the vaccine comes at a time when, according to local authorities, Britain is experiencing “unprecedented” levels of infection, following the onset of the previous days of the coronavirus mutation, which is more easily transmitted, but without causing of the indications so far- most serious disease Covid-19.

The United Kingdom has ordered 100 million doses from AstraZeneca – enough to vaccinate 50 million people.

This is the second vaccine approved in the United Kingdom, after Pfizer and BioNTech. More than 600,000 people in the UK have been vaccinated since 90-year-old Margaret Keenan became the first person to get the Pfizer / BioNTech vaccine out of trial.

With information from Reuters, BBC